skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry using Electron Capture Dissociation and Ultraviolet Photodissociation

Abstract

One challenge associated with the discovery and development of monoclonal antibody (mAb) therapeutics is the de-termination of heavy chain and light chain pairing. Advances in MS instrumentation and MS/MS methods have greatly enhanced capabilities for the analysis of large intact proteins yielding much more detailed and accurate proteoform characterization. Consequently, direct interrogation of intact antibodies or F(ab’)2 and Fab fragments has the poten-tial to significantly streamline therapeutic mAb discovery processes. Here, we demonstrate for the first time the abil-ity to efficiently cleave disulfide bonds linking heavy and light chains of mAbs using electron capture dissociation (ECD) and 157 nm ultraviolet photodissociation (UVPD). The combination of intact mAb, Fab, or F(ab’)2 mass, intact LC and Fd masses, and CDR3 sequence coverage yield unambiguous determination of heavy chain and light chain pair-ing from a single experiment and experimental condition. These results demonstrate the potential of top-down and middle-down proteomics to significantly streamline therapeutic antibody discovery.

Authors:
 [1];  [1];  [2];  [1];  [1];  [3];  [2];  [2]
  1. BATTELLE (PACIFIC NW LAB)
  2. e-MSion Inc.
  3. Mapp Biopharmaceutical, Inc.
Publication Date:
Research Org.:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1581595
Report Number(s):
PNNL-SA-145157
DOE Contract Number:  
AC05-76RL01830
Resource Type:
Journal Article
Journal Name:
Analytical Chemistry
Additional Journal Information:
Journal Volume: 92; Journal Issue: 1
Country of Publication:
United States
Language:
English

Citation Formats

Shaw, Jared B., Liu, Weijing, Vasil'Ev, Yury V., Bracken, Carter C., Malhan, Neha, Guthals, Adrian L., Beckman, Joseph S., and Voinov, Valery G. Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry using Electron Capture Dissociation and Ultraviolet Photodissociation. United States: N. p., 2020. Web. doi:10.1021/acs.analchem.9b03129.
Shaw, Jared B., Liu, Weijing, Vasil'Ev, Yury V., Bracken, Carter C., Malhan, Neha, Guthals, Adrian L., Beckman, Joseph S., & Voinov, Valery G. Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry using Electron Capture Dissociation and Ultraviolet Photodissociation. United States. doi:10.1021/acs.analchem.9b03129.
Shaw, Jared B., Liu, Weijing, Vasil'Ev, Yury V., Bracken, Carter C., Malhan, Neha, Guthals, Adrian L., Beckman, Joseph S., and Voinov, Valery G. Tue . "Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry using Electron Capture Dissociation and Ultraviolet Photodissociation". United States. doi:10.1021/acs.analchem.9b03129.
@article{osti_1581595,
title = {Direct Determination of Antibody Chain Pairing by Top-down and Middle-down Mass Spectrometry using Electron Capture Dissociation and Ultraviolet Photodissociation},
author = {Shaw, Jared B. and Liu, Weijing and Vasil'Ev, Yury V. and Bracken, Carter C. and Malhan, Neha and Guthals, Adrian L. and Beckman, Joseph S. and Voinov, Valery G.},
abstractNote = {One challenge associated with the discovery and development of monoclonal antibody (mAb) therapeutics is the de-termination of heavy chain and light chain pairing. Advances in MS instrumentation and MS/MS methods have greatly enhanced capabilities for the analysis of large intact proteins yielding much more detailed and accurate proteoform characterization. Consequently, direct interrogation of intact antibodies or F(ab’)2 and Fab fragments has the poten-tial to significantly streamline therapeutic mAb discovery processes. Here, we demonstrate for the first time the abil-ity to efficiently cleave disulfide bonds linking heavy and light chains of mAbs using electron capture dissociation (ECD) and 157 nm ultraviolet photodissociation (UVPD). The combination of intact mAb, Fab, or F(ab’)2 mass, intact LC and Fd masses, and CDR3 sequence coverage yield unambiguous determination of heavy chain and light chain pair-ing from a single experiment and experimental condition. These results demonstrate the potential of top-down and middle-down proteomics to significantly streamline therapeutic antibody discovery.},
doi = {10.1021/acs.analchem.9b03129},
journal = {Analytical Chemistry},
number = 1,
volume = 92,
place = {United States},
year = {2020},
month = {1}
}